Occidental announced an offer to exercise its outstanding publicly traded warrants at a temporarily reduced price. The Offer is available to ...

GT Biopharma, Inc. announced that it has entered into agreements to exercise existing warrants for a total of 302,069 shares of its common stock at an exercise price of $4.35, which were issued in ...

Intuitive Machines’ (LUNR) robotic lander touches down on the Moon’s surface around 12:30 p.m. today, the second time it has ...

The proceeds from the exercise of the warrants will be used for general working capital purposes, including Firefly’s recently announced strategic initiative to build the world’s first ...

Roth Capital Partners is acting as the Company's financial advisor for this transaction.

The resale of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-1 (File No. 333-280326).

Occidental Petroleum’s offer to warrant-holders at a reduced exercise price of $21.30 would raise $1.6 billion, the company ...

About Organovo Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug ...

HOUSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced an offer to exercise its outstanding publicly traded warrants (the “Warrants”) at a temporarily reduced price ...

Extends cash runway well into mid-2026; no new/replacement warrants issuedKENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an ...

HOUSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced an offer to exercise its outstanding ...